BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10516663)

  • 1. Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat.
    Kudlacz EM; Whitney CA; Andresen CJ; Umland JP; Cheng JB
    Br J Pharmacol; 1999 Oct; 128(3):788-94. PubMed ID: 10516663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
    J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines induce eosinophil degranulation through CCR-3.
    Fujisawa T; Kato Y; Nagase H; Atsuta J; Terada A; Iguchi K; Kamiya H; Morita Y; Kitaura M; Kawasaki H; Yoshie O; Hirai K
    J Allergy Clin Immunol; 2000 Sep; 106(3):507-13. PubMed ID: 10984371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
    Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
    J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
    J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
    White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
    J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J; Höchstetter R; Kimmig D; Kapp A
    Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells.
    Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; Springer MS; Durham SR; Williams TJ; Kay AB
    Eur J Immunol; 1997 Dec; 27(12):3507-16. PubMed ID: 9464841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human eotaxin induces alpha 4 and beta 2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4.
    Sanz MJ; Ponath PD; Mackay CR; Newman W; Miyasaka M; Tamatani T; Flanagan BF; Lobb RR; Williams TJ; Nourshargh S; Jose PJ
    J Immunol; 1998 Apr; 160(7):3569-76. PubMed ID: 9531320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
    J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
    J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
    Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
    J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.